Klingenstein Fields & Co’s St Jude Medical STJ Stock Holding History

Klingenstein Fields & Co’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,800	Closed	-$385K	–	240
2016 Q4	$385K	Sell	4,800 -540	-10%	-$42.9K	0.02%	173
2016 Q3	$426K	Sell	5,340 -15	-0.3%	-$1.21K	0.02%	156
2016 Q2	$418K	Sell	5,355 -2,000	-27%	-$143K	0.02%	152
2016 Q1	$405K	Hold	7,355	–	–	0.02%	157
2015 Q4	$454K	Hold	7,355	–	–	0.02%	151
2015 Q3	$464K	Hold	7,355	–	–	0.02%	149
2015 Q2	$537K	Hold	7,355	–	–	0.02%	150
2015 Q1	$481K	Buy	7,355 +15	+0.2%	+$997	0.02%	162
2014 Q4	$477K	Hold	7,340	–	–	0.02%	163
2014 Q3	$441K	Hold	7,340	–	–	0.02%	172
2014 Q2	$508K	Hold	7,340	–	–	0.02%	167
2014 Q1	$480K	Hold	7,340	–	–	0.02%	169
2013 Q4	$455K	Hold	7,340	–	–	0.02%	214
2013 Q3	$394K	Buy	7,340 +2,000	+37%	+$103K	0.02%	226
2013 Q2	$244K	Buy	+5,340	New	+$231K	0.01%	282

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Klingenstein Fields & Co's STJ Position: Q1 2017 in Review

Klingenstein Fields & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,800 shares — an estimated $385K sold.

Klingenstein Fields & Co first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $537K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Klingenstein Fields & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Klingenstein Fields & Co sold 4,800 St Jude Medical shares in Q1 2017, an estimated $385K.
Klingenstein Fields & Co first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
Klingenstein Fields & Co's St Jude Medical position peaked at $537K in Q2 2015.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Klingenstein Fields & Co's 13F filing for Q1 2017, filed 1 May 2017.